Skip to main content

Table 5 Relation between demographic data and PDL-1 rs4143815 and rs2297137 in the patient group

From: The genetic influence of PD-1/PD-L1 axis single nucleotide polymorphisms on the incidence of type 1 diabetes mellitus in pediatric Egyptian patients

SNP

 

Genotypes

Age at diagnosis (years)

p value

BMI (Mean ± SD)

p value

Gender

p value

Male

Female

PDL-1 rs4143815 C/G

General

CC

4.15 ± 0.07

NA

44.6 ± 0.0

NA

0 (0%)

2 (3.8)

NA

CG

2.71 ± 0.53

17.9 ± 2.4

14 (50%)

16 (30.8%)

GG

2.48 ± 0.61

18.5 ± 3.2

14 (50%)

34 (65.4%)

Dominant

CC

4.15 ± 0.07

NA

44.6 ± 0.0

NA

0 (0%)

2 (3.8)

NA

CG + GG

2.97 ± 0.58

18.3 ± 2.9

28 (100%)

50 (96.2%)

Recessive

GG

2.84 ± 0.61

0.771

18.5 ± 3.2

0.372

14 (50%)

34 (65.4%)

0.180

CG + CC

2.80 ± 0.63

19.5 ± 7.0

14 (50%)

18 (34.6%)

PDL-1 rs2297137 A/G

General

AA

2.20 ± 0.14

NA

25.0 ± 0.0

NA

0 (0%)

2 (3.8%)

NA

GA

2.89 ± 0.61

20.3 ± 7.7

12 (42.9%)

12 (23.1%)

GG

2.82 ± 0.62

18.1 ± 3.0

16 (57.1%)

38 (73.1%)

Dominant

AA

2.20 ± 0.14

NA

25.0 ± 0.0

NA

0 (0%)

2 (3.8%)

NA

GA + GG

2.84 ± 0.61

18.8 ± 5.0

28(100%)

50 (96.2%)

Recessive

GG

2.82 ± 0.62

0.897

18.1 ± 3.0

0.109

16 (57.1%)

38 (73.1%)

0.147

GA + AA

2.83 ± 0.61

20.6 ± 7.5

12 (42.9%)

14 (26.9%)

  1. BMI, body mass index; NA, non-applicable; SNP, single nucleotide polymorphism; SD, standard deviation; PDL-1, programmed death-ligand 1
  2. *p value is non-applicable due to the small number of cases